Washington Trust Bank Sells 5,648 Shares of UnitedHealth Group Incorporated $UNH

Washington Trust Bank cut its position in UnitedHealth Group Incorporated (NYSE:UNH) by 16.1% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 29,521 shares of the healthcare conglomerate’s stock after selling 5,648 shares during the quarter. Washington Trust Bank’s holdings in UnitedHealth Group were worth $12,270,000 as of its most recent SEC filing.

Other large investors have also added to or reduced their stakes in the company. New Mexico Educational Retirement Board grew its holdings in UnitedHealth Group by 6.1% during the 2nd quarter. New Mexico Educational Retirement Board now owns 45,020 shares of the healthcare conglomerate’s stock worth $18,712,000 after acquiring an additional 2,600 shares during the last quarter. Toth Financial Advisory Corp lifted its holdings in shares of UnitedHealth Group by 25.0% during the second quarter. Toth Financial Advisory Corp now owns 26,164 shares of the healthcare conglomerate’s stock worth $10,874,000 after purchasing an additional 5,232 shares during the period. Mufg Securities Americas Inc. increased its holdings in UnitedHealth Group by 9.1% in the second quarter. Mufg Securities Americas Inc. now owns 27,352 shares of the healthcare conglomerate’s stock valued at $11,368,000 after purchasing an additional 2,292 shares during the period. Nissay Asset Management Corp Japan grew its position in shares of UnitedHealth Group by 2.3% in the 2nd quarter. Nissay Asset Management Corp Japan now owns 120,615 shares of the healthcare conglomerate’s stock valued at $50,131,000 after buying an additional 2,678 shares during the last quarter. Finally, Campbell Newman Asset Management Inc. bought a new position in shares of UnitedHealth Group during the second quarter worth about $45,411,000. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Down 0.3%

UNH opened at $393.99 on Friday. The company has a fifty day moving average price of $413.28 and a two-hundred day moving average price of $360.11. UnitedHealth Group Incorporated has a 1-year low of $255.96 and a 1-year high of $461.62. The company has a current ratio of 0.78, a quick ratio of 0.78 and a debt-to-equity ratio of 0.66. The company has a market cap of $353.64 billion, a P/E ratio of 25.35, a price-to-earnings-growth ratio of 1.36 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, July 16th. The healthcare conglomerate reported $6.38 EPS for the quarter, beating analysts’ consensus estimates of $4.94 by $1.44. The firm had revenue of $112.03 billion during the quarter, compared to analysts’ expectations of $110.81 billion. UnitedHealth Group had a return on equity of 16.53% and a net margin of 3.14%.The company’s revenue for the quarter was up .4% compared to the same quarter last year. During the same quarter last year, the firm posted $4.08 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. Analysts predict that UnitedHealth Group Incorporated will post 19.82 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 22nd. Stockholders of record on Monday, September 14th will be given a dividend of $2.32 per share. The ex-dividend date of this dividend is Monday, September 14th. This represents a $9.28 annualized dividend and a dividend yield of 2.4%. UnitedHealth Group’s payout ratio is presently 59.72%.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on UNH. KeyCorp increased their target price on shares of UnitedHealth Group from $400.00 to $475.00 and gave the company an “overweight” rating in a research report on Tuesday, July 14th. HSBC increased their price objective on shares of UnitedHealth Group from $300.00 to $380.00 and gave the stock a “hold” rating in a research report on Monday, July 6th. UBS Group upped their price target on shares of UnitedHealth Group from $460.00 to $490.00 and gave the company a “buy” rating in a research report on Friday, July 17th. Wells Fargo & Company lifted their price objective on UnitedHealth Group from $397.00 to $485.00 and gave the stock an “overweight” rating in a research report on Monday, July 13th. Finally, Robert W. Baird raised UnitedHealth Group from an “underperform” rating to a “neutral” rating and raised their target price for the stock from $287.00 to $453.00 in a research note on Thursday, July 16th. Two research analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and six have assigned a Hold rating to the company’s stock. According to MarketBeat, UnitedHealth Group presently has an average rating of “Moderate Buy” and a consensus target price of $456.56.

Insiders Place Their Bets

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 1,169 shares of UnitedHealth Group stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $390.00, for a total transaction of $455,910.00. Following the completion of the transaction, the chief executive officer owned 15,328 shares in the company, valued at approximately $5,977,920. The trade was a 7.09% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.19% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.